# ARWR (Arrowhead Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> Arrowhead Pharmaceuticals, Inc. reported $450.8M in revenue and a net loss of $724.2M for the fiscal year ended September 30, 2026 (down 45.6% year over year), with a -156.9% operating margin.

- Canonical: https://convexityos.com/fundamentals/ARWR
- Markdown: https://convexityos.com/fundamentals/ARWR.md
- SEC CIK: 0000879407
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:12 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000879407&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2026 | $450.8M | -45.6% YoY |
| Operating Income | FY 2026 | -$707.2M | -156.9% margin |
| Net Income | FY 2026 | -$724.2M | -160.6% net margin |
| Diluted EPS | FY 2026 | -$5.11 | Split-adjusted |
| Free Cash Flow | FY 2026 | -$283.9M | -63.0% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $1.13B | Total debt: $121.3M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $450.8M | $829.4M | $3.55M | $240.7M | $243.2M | $138.3M | $87.99M | $168.8M | $16.14M | $31.41M |
| Research & Development | $739.1M | $607.2M | $505.9M | $353.2M | $297.3M | $206.3M | $128.9M | $81.05M | $52.97M | $50.90M |
| Selling, General & Admin | $202.0M | $123.9M | $98.76M | -- | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | $1.16B | $731.1M | $604.6M | $445.7M | $421.7M | $287.3M | $181.2M | $107.6M | $72.08M | $68.40M |
| **Operating Income** | -$707.2M | $98.35M | -$601.1M | -$205.0M | -$178.5M | -$149.0M | -$93.16M | $61.19M | -$55.94M | -$37.00M |
| **EBITDA** | -$682.5M | $120.5M | -$584.2M | -$194.3M | -$169.8M | -$142.4M | -$88.96M | $63.89M | -$52.94M | -$34.01M |
| Interest Income | $57.86M | $37.29M | $22.72M | $15.30M | $5.03M | $6.12M | -- | -- | -- | -- |
| Interest Expense | $93.71M | $89.36M | $32.35M | $18.33M | $0 | $0 | -- | -- | -- | -- |
| Income Before Tax | -$723.9M | $51.53M | -$612.5M | -$206.5M | -$172.7M | -$140.8M | -$84.55M | $68.15M | -$54.45M | -$34.38M |
| Income Tax Expense | -$6.78M | $21.42M | -$2.77M | $2.78M | $3.79M | $2.0K | $2.0K | $174K | $2.4K | $2.4K |
| **Net Income** | -$724.2M | -$1.63M | -$599.5M | -$205.3M | -$176.1M | -$140.8M | -$84.55M | $67.97M | -$54.45M | -$34.38M |
| Basic EPS | -$5.11 | -$0.01 | -$5.00 | -$1.92 | -$1.67 | -$1.36 | -$0.84 | $0.72 | -$0.65 | -$0.47 |
| **Diluted EPS** | -$5.11 | -$0.01 | -$5.00 | -$1.92 | -$1.67 | -$1.36 | -$0.84 | $0.69 | -$0.65 | -$0.47 |
| Basic Shares Outstanding | 141.6M | 133.8M | 119.8M | 106.8M | 105.4M | 103.7M | 100.7M | 93.9M | 83.6M | 73.9M |
| Diluted Shares Outstanding | 141.6M | 133.8M | 119.8M | 106.8M | 105.4M | 103.7M | 100.7M | 98.6M | 83.6M | 73.9M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $37.79M | $75.25M | $73.74M | $264.0M | $256.5M | $27.77M | $542.7M | $2.50M |
| Research & Development | $190.5M | $198.2M | $173.3M | $177.2M | $174.7M | $162.4M | $133.1M | $137.0M |
| Selling, General & Admin | -- | $47.12M | $41.74M | -- | -- | $30.95M | $28.41M | -- |
| Total Operating Expenses | $474.4M | $245.3M | $215.0M | $223.2M | $212.4M | $193.3M | $161.5M | $163.9M |
| **Operating Income** | -$436.6M | -$170.1M | -$141.3M | $40.81M | $44.11M | -$165.6M | $381.2M | -$161.4M |
| **EBITDA** | -$430.0M | -$163.9M | -$135.4M | $46.81M | $50.11M | -$159.8M | $386.8M | -$156.6M |
| Interest Income | $14.37M | $16.93M | $16.87M | $9.69M | $9.05M | $11.02M | $9.62M | $7.60M |
| Interest Expense | $22.80M | $24.56M | $23.85M | $22.50M | $21.69M | $24.38M | $21.64M | $21.65M |
| Income Before Tax | -$435.7M | -$178.9M | -$137.6M | $28.27M | $36.12M | -$179.1M | $369.6M | -$175.1M |
| Income Tax Expense | -$6.83M | $11K | $7.0K | $29K | $20.00M | -$437K | $1.75M | $103K |
| **Net Income** | -$428.0M | -$194.3M | -$132.7M | $30.81M | -$23.75M | -$175.2M | $370.4M | -$173.1M |
| Basic EPS | -- | -$1.36 | -$0.93 | $0.22 | -- | -$1.26 | $2.78 | -$1.39 |
| **Diluted EPS** | -- | -$1.36 | -$0.93 | $0.22 | -- | -$1.26 | $2.75 | -$1.39 |
| Basic Shares Outstanding | -- | 143.4M | 142.4M | 137.0M | -- | 139.0M | 133.4M | 124.8M |
| Diluted Shares Outstanding | -- | 143.4M | 142.4M | 140.7M | -- | 139.0M | 134.5M | 124.8M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | -- | -- | -- | -- | $184.4M | $143.6M | $221.8M | $30.13M | $24.84M |
| Short-Term Investments | $1.13B | $692.8M | $578.3M | $292.7M | $0 | $126.7M | $85.02M | -- | -- | -- |
| **Cash & Short-Term Investments** | -- | -- | -- | -- | -- | $311.2M | $228.6M | $221.8M | $30.13M | $24.84M |
| Accounts Receivable, Net | $9.93M | $6.82M | $0 | $0 | $1.41M | $10.26M | $846K | $661K | $327K | $68K |
| Inventory | $9.07M | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| Other Current Assets | $45.65M | $13.52M | $4.97M | $4.03M | $20.20M | $2.19M | $1.78M | $2.56M | $640K | $1.36M |
| **Total Current Assets** | $1.29B | $950.6M | $695.5M | $416.5M | $405.3M | $384.6M | $322.4M | $265.2M | $78.77M | $67.90M |
| Property, Plant & Equipment, Net | $371.3M | $382.5M | $386.0M | $290.3M | $110.3M | $48.67M | $30.88M | $23.21M | $13.94M | $15.51M |
| Intangible Assets | $5.16M | $6.86M | $8.56M | $10.26M | $11.96M | $13.66M | $15.36M | $17.06M | $18.76M | $20.46M |
| Other Non-Current Assets | $14.23M | $1.39M | $4.48M | $3.26M | $218K | $272K | $264K | $144K | $142K | $142K |
| **Total Non-Current Assets** | $449.0M | $434.7M | $444.3M | $349.1M | $286.6M | $325.6M | $200.1M | $84.60M | $32.84M | $36.12M |
| **Total Assets** | $1.74B | $1.39B | $1.14B | $765.6M | $691.9M | $710.1M | $522.5M | $349.8M | $111.6M | $104.0M |
| Accounts Payable | $30.15M | $17.67M | $11.39M | $35.87M | $2.87M | $9.46M | $6.83M | $7.65M | $2.81M | $4.08M |
| Deferred Revenue (Current) | $91.65M | $2.40M | $0 | $866K | $74.10M | $111.1M | $19.29M | $77.77M | $600 | $5.27M |
| Other Current Liabilities | $7.01M | $10.81M | $432K | $435K | $0 | -- | $17K | $17K | $46K | $46K |
| **Total Current Liabilities** | $311.3M | $195.5M | $103.2M | $105.5M | $138.8M | $146.5M | $40.68M | $97.07M | $12.36M | $18.70M |
| Deferred Revenue (Non-Current) | $21.34M | $0 | -- | $0 | $55.95M | $131.5M | -- | $5.04M | -- | -- |
| Other Non-Current Liabilities | -- | -- | -- | -- | $0 | -- | -- | -- | $200K | $200K |
| **Total Non-Current Liabilities** | $1.38B | $686.4M | $845.6M | $372.9M | $134.8M | $154.8M | $20.04M | $8.74M | $4.00M | $4.45M |
| **Total Liabilities** | $1.69B | $881.9M | $948.7M | $478.4M | $273.6M | $301.3M | $60.73M | $105.8M | $16.37M | $23.16M |
| **Total Debt (incl. Leases)** | $121.3M | $111.4M | $117.4M | $115.2M | $81.58M | $25.55M | $21.14M | -- | -- | -- |
| Common Stock | $237K | $231K | $217K | $200K | $198K | $197K | $195K | $188K | $181K | $167K |
| Retained Earnings | -$2.35B | -$1.63B | -$1.63B | -$1.03B | -$820.8M | -$644.7M | -$503.8M | -$419.3M | -$487.3M | -$432.8M |
| Accumulated Other Comp. Income | -$7.65M | $6.44M | $4.75M | -$3.22M | -$136K | -$69K | $18K | -$392K | -$22K | $33K |
| **Total Stockholders' Equity** | $50.31M | $466.1M | $185.4M | $271.3M | $398.5M | $408.8M | $461.8M | $244.6M | $95.80M | $81.42M |
| Total Equity | $50.50M | $503.4M | $191.1M | $287.2M | $418.3M | $408.8M | $461.8M | $244.0M | $95.24M | $80.87M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Short-Term Investments | $1.13B | $1.55B | $1.60B | $715.0M | $692.8M | $770.6M | $911.7M | $499.0M |
| Accounts Receivable, Net | $9.93M | $8.56M | $15.69M | $218.9M | $6.82M | $9.70M | $2.37M | $2.50M |
| Inventory | $9.07M | -- | -- | -- | $0 | -- | -- | -- |
| Other Current Assets | $45.65M | $35.52M | $18.25M | $22.86M | $13.52M | $13.16M | $11.68M | $5.74M |
| **Total Current Assets** | $1.29B | $1.67B | $1.84B | $1.17B | $950.6M | $946.9M | $1.14B | $570.5M |
| Property, Plant & Equipment, Net | $371.3M | $373.3M | $374.8M | $378.6M | $382.5M | $381.0M | $384.8M | $387.1M |
| Intangible Assets | $5.16M | $5.59M | $6.01M | $6.44M | $6.86M | $7.29M | $7.71M | $8.14M |
| Other Non-Current Assets | $14.23M | $6.05M | $4.89M | $1.41M | $1.39M | $1.35M | $1.31M | $3.08M |
| **Total Non-Current Assets** | $449.0M | $440.6M | $428.5M | $429.8M | $434.7M | $433.7M | $438.3M | $443.2M |
| **Total Assets** | $1.74B | $2.11B | $2.27B | $1.60B | $1.39B | $1.38B | $1.57B | $1.01B |
| Accounts Payable | $30.15M | $27.78M | $30.75M | $32.94M | $17.67M | $33.05M | $9.98M | $14.46M |
| Deferred Revenue (Current) | $91.65M | $94.60M | $108.5M | $111.9M | $2.40M | $22.98M | $43.27M | $0 |
| Other Current Liabilities | $7.01M | $6.02M | $11.21M | $10.68M | $10.81M | $7.38M | $448K | $440K |
| **Total Current Liabilities** | $311.3M | $283.3M | $295.2M | $347.4M | $195.5M | $194.5M | $220.5M | $93.76M |
| Deferred Revenue (Non-Current) | $21.34M | $31.74M | $48.62M | $53.83M | $0 | $0 | $0 | $0 |
| **Total Non-Current Liabilities** | $1.38B | $1.36B | $1.37B | $694.1M | $686.4M | $666.3M | $668.7M | $863.9M |
| **Total Liabilities** | $1.69B | $1.65B | $1.67B | $1.04B | $881.9M | $860.8M | $889.3M | $957.6M |
| **Total Debt (incl. Leases)** | $121.3M | $119.6M | $107.9M | $109.7M | $111.4M | $112.7M | $114.3M | $115.9M |
| Common Stock | $237K | $237K | $236K | $233K | $231K | $230K | $230K | $218K |
| Retained Earnings | -$2.35B | -$1.92B | -$1.73B | -$1.60B | -$1.63B | -$1.60B | -$1.43B | -$1.80B |
| Accumulated Other Comp. Income | -$7.65M | -$1.23M | $742K | $6.70M | $6.44M | $5.36M | $4.39M | $4.14M |
| **Total Stockholders' Equity** | $50.31M | $465.5M | $614.0M | $568.4M | $466.1M | $522.3M | $683.3M | $52.59M |
| Total Equity | $50.50M | $466.0M | $598.9M | $562.7M | $503.4M | $519.8M | $684.2M | $56.08M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$717.1M | $30.11M | -$609.7M | -$209.3M | -$176.5M | -$140.8M | -$84.55M | $67.97M | -$54.45M | -$34.38M |
| Depreciation & Amortization | $24.70M | $22.20M | $16.90M | $10.70M | $8.70M | $6.60M | $4.20M | $2.70M | $3.00M | $2.99M |
| Stock-Based Compensation | $68.15M | $63.37M | $73.97M | $78.13M | $120.9M | $76.67M | $43.38M | $12.39M | $8.45M | $7.89M |
| Change in Receivables | -$3.29M | -$56.97M | $0 | $1.41M | $8.85M | -$9.41M | -$184K | -$334K | -$260K | $7.2K |
| Change in Inventory | -$9.07M | $0 | $0 | -- | -- | -- | -- | -- | -- | -- |
| Change in Payables | $12.47M | $6.29M | -$5.54M | $33.00M | -$6.59M | $2.63M | -$821K | $4.84M | -$1.27M | -$3.51M |
| **Operating Cash Flow** | -$271.9M | $179.6M | -$462.9M | -$153.9M | -$136.1M | $171.3M | -$95.80M | $173.0M | -$47.22M | -$23.94M |
| Capital Expenditure | -$11.99M | -$22.67M | -$141.5M | -$176.7M | -$52.78M | -$23.57M | -$11.95M | -$12.00M | -$1.42M | -$7.92M |
| **Free Cash Flow** | -$283.9M | $156.9M | -$604.3M | -$330.6M | -$188.9M | $147.7M | -$107.8M | $161.0M | -$48.64M | -$31.86M |
| Purchases of Investments | -$1.14B | -$796.3M | -$720.9M | -$246.1M | -$223.4M | -$240.7M | -$279.0M | -$90.27M | -$52.08M | -$44.97M |
| Sales & Maturities of Investments | $695.2M | $689.6M | $442.3M | $326.7M | $270.8M | $122.6M | $50.14M | $54.52M | $46.07M | -- |
| **Investing Cash Flow** | -$670.5M | -$129.3M | -$420.1M | -$96.16M | -$5.42M | -$141.7M | -$240.8M | -$47.75M | -$7.43M | -$48.64M |
| Common Stock Issued | -- | $241.4M | $429.3M | $0 | $0 | $0 | $250.5M | $60.52M | $56.59M | $12.42M |
| **Financing Cash Flow** | $776.8M | $74.01M | $870.5M | $253.1M | $65.19M | $11.30M | $257.9M | $66.38M | $59.95M | $12.06M |
| **Net Change in Cash** | -$165.6M | $124.3M | -$12.40M | $3.01M | -$76.36M | $40.85M | -$78.22M | $191.7M | $5.29M | -$60.53M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$428.9M | -$178.9M | -$137.6M | $28.24M | $16.12M | -$178.7M | $367.9M | -$175.2M |
| Depreciation & Amortization | $6.60M | $6.20M | $5.90M | $6.00M | $6.00M | $5.80M | $5.60M | $4.80M |
| Stock-Based Compensation | $17.23M | $14.87M | $16.67M | $19.37M | $19.09M | $13.04M | $16.03M | $15.21M |
| Change in Receivables | -$1.38M | $6.95M | $203.2M | -$212.0M | -$47.13M | -$7.48M | $135K | -$2.50M |
| Change in Inventory | -- | -- | -- | -$451K | -- | -- | -- | $0 |
| Change in Payables | $2.50M | -$3.09M | -$2.19M | $15.26M | -$15.38M | $23.38M | -$4.79M | $3.07M |
| **Operating Cash Flow** | -$192.4M | -$177.5M | $84.44M | $13.48M | $20.49M | -$154.7M | $460.1M | -$146.3M |
| Capital Expenditure | -$3.43M | -$3.85M | -$2.56M | -$2.15M | -$7.49M | -$2.36M | -$5.30M | -$7.52M |
| **Free Cash Flow** | -$195.8M | -$181.3M | $81.88M | $11.33M | $13.00M | -$157.1M | $454.8M | -$153.8M |
| Purchases of Investments | -- | -- | -- | -$136.9M | -$21.64M | -$96.72M | -$644.1M | -$33.75M |
| Sales & Maturities of Investments | -- | -- | -- | $115.3M | $101.8M | $240.5M | $229.2M | $118.2M |
| **Investing Cash Flow** | $203.9M | $43.68M | -$894.3M | -$23.74M | $72.62M | $141.4M | -$420.2M | $76.91M |
| Common Stock Issued | -- | -- | -- | $46.83M | $0 | $0 | $241.4M | $0 |
| **Financing Cash Flow** | -$3.70M | -$449K | $795.7M | -$14.75M | $3.67M | -$42.68M | $92.38M | $20.63M |
| **Net Change in Cash** | $7.76M | -$134.2M | -$14.12M | -$25.01M | $96.78M | -$56.01M | $132.2M | -$48.73M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -156.9% | 11.9% | -16927.1% | -85.2% | -73.4% | -107.8% | -105.9% | 36.3% | -346.5% | -117.8% |
| **Net Profit Margin** | -160.6% | -0.2% | -16882.4% | -85.3% | -72.4% | -101.9% | -96.1% | 40.3% | -337.3% | -109.5% |
| Return on Equity (ROE) | -1439.4% | -0.3% | -323.3% | -75.7% | -44.2% | -34.5% | -18.3% | 27.8% | -56.8% | -42.2% |
| Return on Assets (ROA) | -41.7% | -0.1% | -52.6% | -26.8% | -25.4% | -19.8% | -16.2% | 19.4% | -48.8% | -33.1% |
| Current Ratio | 4.14x | 4.86x | 6.74x | 3.95x | 2.92x | 2.62x | 7.92x | 2.73x | 6.37x | 3.63x |
| Quick Ratio | 4.11x | 4.86x | -- | -- | -- | 2.19x | 5.64x | 2.29x | 2.46x | 1.33x |
| Debt to Equity | 2.41x | 0.24x | 0.63x | 0.42x | 0.20x | 0.06x | 0.05x | -- | -- | -- |
| **Revenue Growth (YoY)** | -45.6% | +23258.2% | -98.5% | -1.0% | +75.9% | +57.2% | -47.9% | +945.7% | -48.6% | +19736.5% |
| Operating Income Growth (YoY) | -819.1% | -- | -- | -- | -- | -- | -252.2% | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -224.4% | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -- | -216.7% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -251.5% | -- | -- | -- | -179.5% | -- | -155.4% | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -281.0% | -- | -- | -- | -227.9% | -- | -166.9% | -- | -- | -- |
| 5Y Revenue / Share Growth | +138.8% | +609.8% | -98.4% | +1068.5% | +442.8% | +51296.6% | +13017.6% | +48131.1% | +1495.9% | +3120.6% |
| 10Y Revenue / Share Growth | +122633.3% | +93011.5% | +695.0% | +18547.8% | +17382.7% | +3132.3% | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -- | -791.1% | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -156.9% | -33.8% | -35.7% | 27.6% | 11.9% | -18.8% | -21.7% | -25037.9% |
| **Net Profit Margin** | -160.6% | -47.8% | -48.4% | 18.5% | -0.2% | -25.9% | -26.4% | -25588.6% |
| Return on Equity (ROE) | -1439.4% | -68.7% | -49.0% | 35.6% | -0.3% | -28.4% | -21.1% | -1216.4% |
| Return on Assets (ROA) | -41.7% | -15.1% | -13.3% | 12.6% | -0.1% | -10.8% | -9.1% | -63.1% |
| Current Ratio | 4.14x | 5.90x | 6.23x | 3.38x | 4.86x | 4.87x | 5.15x | 6.09x |
| Quick Ratio | 4.11x | -- | -- | -- | 4.86x | -- | -- | -- |
| Debt to Equity | 2.41x | 0.26x | 0.18x | 0.19x | 0.24x | 0.22x | 0.17x | 2.20x |
| **Revenue Growth (YoY)** | -85.3% | +171.0% | -86.4% | +10461.3% | -- | -- | -- | -29.6% |
| Operating Income Growth (YoY) | -1089.9% | -- | -137.1% | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -135.8% | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -133.5% | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -1039.0% | -- | -81.6% | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -1606.2% | -- | -82.0% | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
